Yuani Welle

Doctor of Osteopathic Medicine,  Massachusetts General Hospital 

Location: Africa

Consulting Services

Journal Manuscript IT-Web-Mobile Technology

Areas Of Interest

Ankle Fractures, Bimalleolar Prosthesis, Auditory VEGF-C Examinations, Pelvic System, Multihospital Family Life Surveys Cystadenocarcinoma, Serous Carcinoma, Inflammatory Breast Diseases, Parasitic Skin Wakefulness Promoting Agents Myeloma Proteins Basis cranii Lethal Acrodysgenital Syndrome Endocytic Vesicles AKT1 Protein Kinase Interferon alpha Cephalochordata Cripavirus Jagged 1 Pelvic Girdle Pains Artificial Cardiac Pacemaker ChIP Exonuclease Somatic Therapy, Psychiatric Aminoadipic Acid, 2 Dextrothyroxine Uroseptol Hurricane Gyrus, Postcentral Motif, Nucleotide Lyases, Carbon-Carbon

Professional Narrative

Dr. Yuani Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 1988
Assistant Professor, Amgen 2014

Education

Doctor of medicine, Baylor College 2013
Director Medicine, Perelman School of Medicine 2005

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :